Literature DB >> 15863542

The incidence of large fetomaternal hemorrhage and the Kleihauer-Betke test.

Raed Salim1, Izhar Ben-Shlomo, Zohar Nachum, Rivka Mader, Eliezer Shalev.   

Abstract

OBJECTIVE: To assess the frequency of large fetomaternal hemorrhage and to estimate its incidence in cesarean compared with vaginal deliveries.
METHODS: In this prospective cohort study, the study group was composed of 313 women who underwent cesarean delivery. Control subjects were 253 women who delivered vaginally and were matched for age, parity, ethnic origin, and gestational age. Ninety-six pregnant women at term, but before delivery (prelabor group), were also included to determine whether delivery itself is the cause of fetomaternal hemorrhage. Fetomaternal hemorrhage was measured by using the Kleihauer-Betke test.
RESULTS: Twenty women (6.4%) in the study group and 17 (6.7%) in the control group had a large fetomaternal hemorrhage (Kleihauer-Betke test > 0.4%). Five women (5.2%) in the prelabor group had a large fetomaternal hemorrhage. The differences were not significant. A large fetomaternal hemorrhage occurred in 14 of 146 (9.6%) women who underwent emergency cesarean, compared with 6 of 167 (3.5%) who delivered by elective cesarean (P = .04). In deliveries complicated by oligohydramnios, cord around the neck, or low birth weight, a higher rate of large fetomaternal hemorrhage was seen.
CONCLUSION: Our results indicate a rate of large fetomaternal hemorrhage that is substantially higher than previously reported, with no difference between vaginal and cesarean deliveries. This may reflect inaccuracies with the current method used to estimate the degree of fetomaternal hemorrhage.

Entities:  

Mesh:

Year:  2005        PMID: 15863542     DOI: 10.1097/01.AOG.0000157115.05754.3c

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  The importance of antenatal prevention of RhD immunisation in the first pregnancy.

Authors:  Slavica Dajak; Damir Roje; Željka Hundrić Hašpl; Pera Erceg Maglić
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

2.  Reaction to anti-D immunoglobulin - can we manage it?

Authors:  Katherine O'Brien; Dimitrios Siassakos; Janet Birchall; Mark Gompels; Sarah Allford; Ken Bidgood
Journal:  Obstet Med       Date:  2009-03-01

3.  Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.

Authors:  Fekadu Urgessa; Aster Tsegaye; Yirgu Gebrehiwot; Asaye Birhanu
Journal:  BMC Pregnancy Childbirth       Date:  2014-11-07       Impact factor: 3.007

4.  Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.

Authors:  Y M Slootweg; C Zwiers; J M Koelewijn; E van der Schoot; D Oepkes; I L van Kamp; M de Haas
Journal:  BJOG       Date:  2022-03-18       Impact factor: 7.331

5.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.